Sysmex Co. (OTCMKTS:SSMXY) Short Interest Update

Sysmex Co. (OTCMKTS:SSMXY) was the target of a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 4,000 shares, a decrease of 79.7% from the January 31st total of 19,700 shares. Based on an average daily trading volume, of 113,800 shares, the short-interest ratio is presently 0.0 days.

Sysmex Stock Performance

OTCMKTS:SSMXY traded up $0.28 during midday trading on Thursday, reaching $18.39. The stock had a trading volume of 40,990 shares, compared to its average volume of 75,632. Sysmex has a 12-month low of $14.38 and a 12-month high of $28.58. The stock has a market cap of $11.58 billion, a P/E ratio of 35.74 and a beta of 0.90. The company has a quick ratio of 2.42, a current ratio of 3.19 and a debt-to-equity ratio of 0.11. The firm has a fifty day simple moving average of $18.50 and a two-hundred day simple moving average of $19.13.

Sysmex (OTCMKTS:SSMXY) last released its quarterly earnings data on Wednesday, February 12th. The company reported $0.17 EPS for the quarter. On average, equities analysts expect that Sysmex will post 0.57 EPS for the current year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.